Primary Pulmonary Hypertension as a Risk Factor for the Development of Obliterative Bronchiolitis in Lung Allograft Recipients
Authors:
- Timothy J. KroshusTKTimothy J. Kroshus
- Kay SavikKSKay Savik
- Marshall I. HertzMHMarshall I. Hertz
- R. Morton BolmanRBR. Morton Bolman
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Experimental large-animal model of obliterative bronchiolitis after lung transplantationThe Annals of Thoracic Surgery, 1994
- ARE MULTIPLE IMMUNOPATHOGENETIC EVENTS OCCURRING DURING THE DEVELOPMENT OF OBLITERATIVE BRONCHIOLITIS AND ACUTE REJECTION?Transplantation, 1993
- Lung and Heart-Lung TransplantationAnnals of Surgery, 1991
- Survival in Patients with Primary Pulmonary HypertensionAnnals of Internal Medicine, 1991
- Improved technique for bilateral lung transplantation: Rationale and initial clinical experienceThe Annals of Thoracic Surgery, 1990
- High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.Circulation, 1987
- TWENTY-EIGHT CASES OF HUMAN HEART-LUNG TRANSPLANTATIONThe Lancet, 1986
- Heart-Lung TransplantationNew England Journal of Medicine, 1982
- Oral Hydralazine Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958